Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency

Children
doi 10.3390/children2010108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

What Is the European Medicines Agency?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2012English

FDA Reform and the European Medicines Evaluation Agency

Harvard Law Review
Law
1995English

The European Medicines Agency's Approval of New Medicines for Type 2 Diabetes

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

Developing New Medicines for the Treatment of Pain

Prescriber
Pharmacology
2019English

European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies

mAbs
AllergyImmunology
2009English

European Medicines Agency Policies for Clinical Trials Leave Women Unprotected

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2006English

PReS13-SPK-1408: New EU Scientific Guidelines for JIA, SLE and GIOP From the European Medicines Agency

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Pro Labeling in Products Approved by the European Medicines Agency (EMA) for Narcolepsy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy